Ovarian endometriosis associated with significantly elevated CA19-9: a case report
Frontiers in Oncology · 21.07.2026 · 16
DOI: 10.3389/fonc.2026.1846804 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Oncology, online erschienen am 21.07.2026. Verfasst von Yue Hu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Carbohydrate antigen 19-9 (CA19-9) is a well-established tumour marker primarily associated with pancreaticobiliary and gastrointestinal malignancies. Its elevation in benign gynaecological conditions, particularly in isolated ovarian endometriosis (OE) without malignancy, is rare and can pose a significant diagnostic challenge. Case presentation In this case report, a 44-year-old female was found to have significantly elevated CA19-9 (up to 2453.1 U/mL), accompanied by left lower abdominal dull pain and weight loss. She was first diagnosed with an ovarian cyst more than 20 years ago, which resolved during pregnancy and recurred postpartum with no special intervention due to the absence of clinical symptoms. Extensive workup, including gastroenterological endoscopy and abdominal magnetic resonance imaging (MRI), excluded gastrointestinal malignancies. Laparoscopy followed by pathological examination confirmed the diagnosis of an ovarian endometriotic cyst (chocolate cyst). Postoperatively, the patient received standardised endocrine therapy, and follow-up assessments showed that serum CA19–9 levels returned to the normal range with no evidence of lesion recurrence.
Conclusions
For female patients with elevated CA19−9 combined with a long−standing ovarian cyst and pelvic symptoms, ovarian malignancy should be suspected after excluding gastrointestinal lesions. However, benign diseases should also be considered. The final diagnosis should be based on comprehensive clinical evaluation, additional laboratory and imaging findings, and ultimately confirmed by pathological biopsy. Clinicians need to strengthen the cognitive understanding of this atypical manifestation to reduce misdiagnosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Graduate School, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
- The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, China.
- Department of Gynecology, Shenzhen Hospital of Traditional Chinese Medicine, Shenzhen, China.
Zitieren
APA
Hu, Y., Ruan, J., & Du, X. (2026). Ovarian endometriosis associated with significantly elevated CA19-9: a case report. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1846804
Vancouver
Hu Y, Ruan J, Du X. Ovarian endometriosis associated with significantly elevated CA19-9: a case report. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1846804
BibTeX
@article{Hu2026,
author = {Hu, Yue and Ruan, Jiali and Du, Xuelian},
title = {Ovarian endometriosis associated with significantly elevated CA19-9: a case report},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1846804}
}
EUVIMED